Zobrazeno 1 - 10
of 109
pro vyhledávání: '"M. A. Pacciarini"'
Autor:
L. Alborali, Nicola Ferrari, Maria Beatrice Boniotti, Dominga Avisani, Mario Chiari, Mariagrazia Zanoni, Daniele Giardiello, M. L. Pacciarini
Publikováno v:
Transboundary and Emerging Diseases. 63:e381-e388
Summary Mycobacterium microti has recently been described as the causative agent of tuberculosis-like lesions in wild boar (Sus scrofa), a reservoir specie of Mycobacterium tuberculosis complex (MTBC) in some European Mediterranean ecosystem. Through
Autor:
Angela Scaburri, Cinzia Pellizzoni, Guido Kroemer, Bernard Laffranchi, Rastilav Balheda, Christophe Massard, Jean-Charles Soria, Chris Twelves, Jean-Pierre Armand, M. A. Pacciarini, A Proctor, D. Alan Anthoney
Publikováno v:
Cell Cycle. 10:963-970
PHA-793887 is an inhibitor of multiple cyclin dependent kinases (CDK) with activity against CDK2, CDK1 and CDK4. The primary objectives of this first in man study were to determine the dose limiting toxicities (DLTs), maximum tolerated dose (MTD) and
Autor:
M. Beatrice Boniotti, Alessandro Benedetto, Annalisa Garrone, Maria Goria, Alessandro Dondo, Daniela Loda, Alessandra Mondo, Simona Zoppi, Silvia Tagliabue, Stefano Bonora, Mariagrazia Zanoni, Giorgio Zanardi, M. Lodovica Pacciarini, Ernesto Tisato
Publikováno v:
Journal of Clinical Microbiology. 47:636-644
Spoligotyping and exact tandem repeat (ETR) analysis of Mycobacterium bovis and M. caprae isolated strains has been routinely carried out in Italy since 2000 to obtain a database of genetic profiles and support traditional epidemiological investigati
Publikováno v:
Veterinary Microbiology. 130:338-347
In this study, the isolation of 52 mycobactin-independent fast growing mycobacteria from 631 bulk milk samples (8.2%), is reported. These strains, isolated during a bulk milk survey for Mycobacterium avium subsp. paratuberculosis (Map), strongly affe
Publikováno v:
Repositorio de Resultados de Investigación del INIA
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria INIA
INIA: Repositorio de Resultados de Investigación del INIA
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria INIA
INIA: Repositorio de Resultados de Investigación del INIA
The origin and evolution of the type O foot-and-mouth disease viruses (FMDV) that caused the outbreak occurrence in Italy in 1993, the first episode of the disease in the EU after adoption of a non-vaccination policy in 1991, have been studied by the
Autor:
Margherita Strolin-Benedetti, M. Rocchetti, Steve Toon, Beverly I Holt, S. Persiani, M. A. Pacciarini
Publikováno v:
Biopharmaceutics & Drug Disposition. 17:443-455
The effect of food on the pharmacokinetics and tolerability of cabergoline in man was investigated. For this purpose an open, randomized, single-dose study was conducted in 12 healthy male volunteers who received 1 mg cabergoline as tablets both unde
Autor:
Antonio Jimeno, Angela Scaburri, Ramesh K. Ramanathan, Lisa Blaydorn, Marina Ciomei, Glen J. Weiss, Raoul Tibes, Mitesh J. Borad, Daniel D. Von Hoff, M. A. Pacciarini, Gayle S. Jameson, Manuel Hidalgo, Francesco Fiorentini, Daniel A. Laheru, Jeffrey D. Isaacs
Purpose This phase I trial assessed the safety, maximally tolerated dose (MTD) and pharmacokinetics of TRKA/CDK inhibitor PHA-848125AC in adult patients with advanced/metastatic solid tumors. Patients and methods Patients with relapsed or refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6886b925ebc3df3fb0f9c219fe60f32c
https://europepmc.org/articles/PMC3561458/
https://europepmc.org/articles/PMC3561458/
Publikováno v:
Scopus-Elsevier
Primers for PCR were selected from a sequenced fragment of clone pL590, which contains a repetitive element present in the genome of Leptospira interrogans serovar hardjo type hardjoprajitno (M. L. Pacciarini, M. L. Savio, S. Tagliabue, and C. Rossi,
Publikováno v:
The Veterinary record. 142(6)
Publikováno v:
Biopharmaceuticsdrug disposition. 17(5)
The effect of food on the pharmacokinetics and tolerability of cabergoline in man was investigated. For this purpose an open, randomized, single-dose study was conducted in 12 healthy male volunteers who received 1 mg cabergoline as tablets both unde